Cellectis Reports Third Quarter and First Nine Months 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Cellectis (CLLS) Misses Q2 EPS by 5c
November 16, 2015 5:02 PM ESTCellectis (NASDAQ: CLLS) reported Q2 EPS of (EUR0.36), EUR0.05 worse than the analyst estimate of (EUR0.31). Revenue for the quarter came in at EUR1 million versus the consensus estimate of EUR5.6 million.
As of September 30, 2015 Cellectis had 279.4 million in cash and cash equivalents compared to... More



